These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 2571728)

  • 1. Sterically hindered 5,11-dicarbo analogues of clozapine as potential chiral antipsychotic agents.
    Rupard JH; de Paulis T; Janowsky A; Smith HE
    J Med Chem; 1989 Oct; 32(10):2261-8. PubMed ID: 2571728
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Chloro-substituted, sterically hindered 5,11-dicarbo analogues of clozapine as potential chiral antipsychotic agents.
    Davis DA; de Paulis T; Janowsky A; Smith HE
    J Med Chem; 1990 Feb; 33(2):809-14. PubMed ID: 1967652
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Binding of 5H-dibenzo[b,e][1,4]diazepine and chiral 5H-dibenzo[a,d]cycloheptene analogues of clozapine to dopamine and serotonin receptors.
    Phillips ST; de Paulis T; Baron BM; Siegel BW; Seeman P; Van Tol HH; Guan HC; Smith HE
    J Med Chem; 1994 Aug; 37(17):2686-96. PubMed ID: 8064797
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synthesis of clozapine analogues and their affinity for clozapine and spiroperidol binding sites in rat brain.
    de Paulis T; Betts CR; Smith HE; Mobley PL; Manier DH; Sulser F
    J Med Chem; 1981 Sep; 24(9):1021-6. PubMed ID: 7288815
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Binding of 5H-dibenzo[a,d]cycloheptene and dibenz[b,f]oxepin analogues of clozapine to dopamine and serotonin receptors.
    Phillips ST; de Paulis T; Neergaard JR; Baron BM; Siegel BW; Seeman P; Van Tol HH; Guan HC; Smith HE
    J Med Chem; 1995 Feb; 38(4):708-14. PubMed ID: 7861418
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synthesis and biological evaluation of some 2-amino-4-aryl-3H-1,5-benzodiazepine analogues of clozapine.
    Ellefson CR; Woo CM; Miller A; Kehr JR
    J Med Chem; 1978 Sep; 21(9):952-7. PubMed ID: 31487
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synthesis and pharmacological evaluation of triflate-substituted analogues of clozapine: identification of a novel atypical neuroleptic.
    Liao Y; DeBoer P; Meier E; Wikström H
    J Med Chem; 1997 Dec; 40(25):4146-53. PubMed ID: 9406603
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Affinity of 10-(4-methylpiperazino)dibenz[b,f]oxepins for clozapine and spiroperidol binding sites in rat brain.
    Harris TW; Smith HE; Mobley PL; Manier DH; Sulser F
    J Med Chem; 1982 Jul; 25(7):855-8. PubMed ID: 7108902
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Use of the butaclamol template in a search for antipsychotic agents with lessened side effects.
    Kukla MJ; Bloss JL; Brougham LR
    J Med Chem; 1979 Apr; 22(4):401-6. PubMed ID: 34721
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long-term treatment with antipsychotics does not alter the phosphoinositide response to muscarinic or D2 dopaminergic agonists in rat striatum.
    Rubinstein JE; Hitzemann RJ; Ashby CR; Wang RY
    Brain Res; 1989 Sep; 496(1-2):385-8. PubMed ID: 2572294
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pyrrolo[1,3]benzothiazepine-based serotonin and dopamine receptor antagonists. Molecular modeling, further structure-activity relationship studies, and identification of novel atypical antipsychotic agents.
    Campiani G; Butini S; Fattorusso C; Catalanotti B; Gemma S; Nacci V; Morelli E; Cagnotto A; Mereghetti I; Mennini T; Carli M; Minetti P; Di Cesare MA; Mastroianni D; Scafetta N; Galletti B; Stasi MA; Castorina M; Pacifici L; Vertechy M; Di Serio S; Ghirardi O; Tinti O; Carminati P
    J Med Chem; 2004 Jan; 47(1):143-57. PubMed ID: 14695828
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synthesis and pharmacological evaluation of 11-(1,6-dimethyl-1,2,3,6-tetrahydropyridin-4-yl)-5H-dibenzo[b,e][1,4]diazepines with clozapine-like receptor occupancy at dopamine D
    Watanabe H; Ishida K; Yamamoto M; Horiguchi M; Isobe Y
    Bioorg Med Chem Lett; 2020 Nov; 30(21):127563. PubMed ID: 32976928
    [TBL] [Abstract][Full Text] [Related]  

  • 13. New (sulfonyloxy)piperazinyldibenzazepines as potential atypical antipsychotics: chemistry and pharmacological evaluation.
    Liao Y; Venhuis BJ; Rodenhuis N; Timmerman W; Wikström H; Meier E; Bartoszyk GD; Böttcher H; Seyfried CA; Sundell S
    J Med Chem; 1999 Jun; 42(12):2235-44. PubMed ID: 10377229
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effects of clozapine and fluperlapine on the in vivo release and metabolism of dopamine in the striatum and in the prefrontal cortex of freely moving rats.
    Imperato A; Angelucci L
    Psychopharmacol Bull; 1989; 25(3):383-9. PubMed ID: 2576318
    [TBL] [Abstract][Full Text] [Related]  

  • 15. One year treatment with haloperidol or clozapine fails to alter neostriatal D1- and D2-dopamine receptor sensitivity in the rat.
    Ashby CR; Hitzemann R; Rubinstein JE; Wang RY
    Brain Res; 1989 Jul; 493(1):194-7. PubMed ID: 2570618
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Homobivalent ligands of the atypical antipsychotic clozapine: design, synthesis, and pharmacological evaluation.
    McRobb FM; Crosby IT; Yuriev E; Lane JR; Capuano B
    J Med Chem; 2012 Feb; 55(4):1622-34. PubMed ID: 22243698
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of acute and chronic treatments with clozapine and haloperidol on serotonin (5-HT2) and dopamine (D2) receptors in the rat brain.
    Wilmot CA; Szczepanik AM
    Brain Res; 1989 May; 487(2):288-98. PubMed ID: 2525063
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Differential regulation of D2 and D4 dopamine receptor mRNAs in the primate cerebral cortex vs. neostriatum: effects of chronic treatment with typical and atypical antipsychotic drugs.
    Lidow MS; Goldman-Rakic PS
    J Pharmacol Exp Ther; 1997 Nov; 283(2):939-46. PubMed ID: 9353417
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pyridobenzoxazepine and pyridobenzothiazepine derivatives as potential central nervous system agents: synthesis and neurochemical study.
    Liégeois JF; Rogister FA; Bruhwyler J; Damas J; Nguyen TP; Inarejos MO; Chleide EM; Mercier MG; Delarge JE
    J Med Chem; 1994 Feb; 37(4):519-25. PubMed ID: 7907148
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evidence for different states of the dopamine D1 receptor: clozapine and fluperlapine may preferentially label an adenylate cyclase-coupled state of the D1 receptor.
    Andersen PH; Braestrup C
    J Neurochem; 1986 Dec; 47(6):1822-31. PubMed ID: 2945903
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.